Annals of Epidemiology
Volume 9, Issue 5 , Pages 290-296 , July 1999

Cigarette Smoking, Environmental Tobacco Smoke Exposure and Insulin Sensitivity: The Insulin Resistance Atherosclerosis Study

  • Leora Henkin, MPH,MEd

      Affiliations

    • Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC USA
    • Corresponding Author InformationReprint requests to Leora Henkin, Department of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157–1063
    • ,
  • Daniel Zaccaro, MS

      Affiliations

    • Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC USA
    • ,
  • Steven Haffner, MD

      Affiliations

    • Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX USA
    • ,
  • Andrew Karter, PhD

      Affiliations

    • Kaiser Permanente Division of Research, Oakland, CA USA
    • ,
  • Marian Rewers, MD, PhD

      Affiliations

    • Department of Preventive Medicine/Biometrics, University of Colorado Health Science Center, Denver, CO USA
    • ,
  • Phyliss Sholinsky, MSPH

      Affiliations

    • National Heart, Lung and Blood Institute, Division of Epidemiology and Clinical Applications, National Institutes of Health, Bethesda, MD USA
    • ,
  • Lynne Wagenknecht, DrPH

      Affiliations

    • Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC USA

Received 20 April 1998 ,Revised 30 December 1998 ,Accepted 7 January 1999.

References 

  1. Kannel WB, D’Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease (insights from the Framingham study). Am Heart J. 1987;113:1006–1010
  2. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J. 1981;101:319–328
  3. Howard G, Burke GL, Szklo M, Tell GS, Eckfeldt J, Evans G, et al. Active and passive smoking are associated with increased carotid wall thickness (The Atherosclerosis Risk in Communities Study). Arch Intern Med. 1994;154:1277–1282
  4. Olofson B, Dahlen G, Nilsson T. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J. 1989;10:77–82
  5. Facchini FS, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128–1130
  6. Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health. 1993;83:211–214
  7. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1986;315:220–224
  8. Howard B, et al.  Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics and non-Hispanic whites (The Insulin Resistance Atherosclerosis Study). Metabolism. 1998;47:1174–1179
  9. Attvall S, Fowelin J, Lager I, von Schenck H, Smith U. Smoking induces insulin resistance (a potential link with the insulin resistance syndrome). J Int Med. 1993;233:327–332
  10. Rönnemaa T, Rönnemaa EM, Puukka P, Pyörälä K, Laakso M. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diab Care. 1996;19:1229–1232
  11. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, et al.  The Insulin Resistance Atherosclerosis Study (IRAS) Objectives, Design and Recruitment Results. Ann Epidemiol. 1995;5:464–471
  12. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans (the San Antonio Heart Study). Am J Epidemiol. 1984;120:834–851
  13. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, et al.  Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. Am J Epidemiol. 1989;129:295–311
  14. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. End Rev. 1985;6:45–86
  15. Yang Y, Youn JH, Bergman RN. Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol. 1987;253:E595–E602
  16. Pacini G, Bergman RN. MINMOD (A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test). Computer Methods Programs Biomed. 1986;23:113–122
  17. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, et al.  A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. 1994;43:1114–1121
  18. World Health Organization . Diabetes Mellitus (Report of a WHO Study Group. Technical Report Series No. 727). Geneva, Switzerland: World Health Organization; 1985;
  19. Lohman TG, Roche AF, Mortorell R. Anthropometric Standardization Reference Manual (abridged edition). Champaign, IL: Human Kinetics Publishers, Inc; 1991;
  20. Helve E, Yki-Jarvinen H, Koivisto V. Smoking and insulin sensitivity in type 1 diabetic patients. Metabolism. 1986;35:874–877
  21. Surveillance for smoking-attributable mortality and years of potential life lost, by state—United States, 1990. MMWR. 1994;43:1–8.
  22. National Research Council . Environmental Tobacco Smoke (Measuring Exposures and Assessing Health Effects). Washington, DC: National Academy Press; 1986;
  23. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Smoking. A Report of the Surgeon General. DHHS Pub. No. (PHS) 87-8398. U.S. DHHS, Public Health Service, Office of the Assistant Secretary for Health, Office of Smoking and Health, Washington, DC; 1986.
  24. Guerin MR, Jenkins RA, Tomkins BA. The Chemistry of Environmental Tobacco Smoke (Composition and Measurement). Chelsea, MI: Lewis Publishers; 1992;
  25. U.S. Environmental Protection Agency. Respiratory Health Effects of Passive Smoking; Lung Cancer and Other Disorders. EPA/600/6-90-006F; Office of Health and Environmental Assessment Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC; 1992.
  26. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril. 1987;47:398–401
  27. Khaw KT, Tazuke S, Barret-Connor E. Cigarette smoking and level of adrenal androgens in post-menopausal women. N Engl J Med. 1988;1705–1709.
  28. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study (A comparison of self-report with serum cotinine levels). Am J Public Health. 1992;82:33–36

PII: S1047-2797(99)00003-4

Annals of Epidemiology
Volume 9, Issue 5 , Pages 290-296 , July 1999

Article Tools